The flaw affects OpenEMR versions before 8.3.0.The vendor advisory says an untrusted warehouse value reaches a dynamically built database sort clause without adequate validation. An authenticated user with Fee Sheet access can abuse the flaw to read data through a blind timing channel.
What it allows
How Does CVE-2026-124469 Affect OpenEMR?
An attacker needs an authenticated account whose role can use the Fee Sheet form. The vendor says a default installation can grant this access to low-privileged clinical staff.
Successful exploitation can expose data across the OpenEMR database. The advisory specifically identifies patient records and password hashes as accessible information, creating further account-takeover risk.
The vendor describes the direct database primitive as read-only under default grants. It also states that the default configuration does not provide a path to remote code execution.
Who is affected
OpenEMR versions earlier than 8.3.0 are affected. The GitHub security advisory identifies OpenEMR 8.3.0 as the patched version.
Exposure depends on whether an authenticated role can access the Fee Sheet workflow. Internet-facing login access increases the opportunity for a compromised low-privileged account to reach the vulnerable function.
What to do
-
Upgrade OpenEMR to version 8.3.0 or later
Prioritize systems where clinical staff or other low-privileged roles can use Fee Sheets. Confirm the running application version after deployment.
-
Review Fee Sheet permissions
Brandefense recommends limiting Fee Sheet access to staff who need it. Remove unnecessary access while the upgrade is being completed.
-
Investigate unusual Fee Sheet activity
Brandefense recommends reviewing application and database logs for repeated or unusual Fee Sheet submissions. Preserve relevant logs and investigate activity tied to unexpected accounts.
-
Assess exposed credentials after suspected abuse
The advisory says the flaw can expose password hashes. If investigation indicates abuse, follow the organization's credential reset and incident response procedures.
What Brandefense can do
- Watch your stack for exploited flaws
Name the vendors and products you run, and Brandefense alerts you when a CVE in them is exploited.
- See CVE-2026-124469 in Brandefense Atlas
The Atlas record of CVE-2026-124469: severity, exploitation status and the sources behind it.
- Vulnerability intelligence platform
Brandefense Vulnerability Intelligence follows which vulnerabilities attackers are using, so your team can patch what is under attack first.
Frequently Asked Questions
What is CVE-2026-124469?
It is an SQL injection vulnerability in the OpenEMR Fee Sheet drug-inventory lookup. The flaw can let an authenticated user with Fee Sheet access read sensitive database information.
Which OpenEMR versions are affected by CVE-2026-124469?
The GitHub security advisory lists OpenEMR versions before 8.3.0 as affected. It identifies version 8.3.0 as patched.
Does CVE-2026-124469 require authentication?
Yes. The advisory says exploitation requires an authenticated role that can access the Fee Sheet form, including certain low-privileged clinical roles in a default installation.
What should OpenEMR administrators do first?
Upgrade to OpenEMR 8.3.0 or later. Administrators should also review Fee Sheet permissions and investigate unusual submissions while completing the upgrade.